Thanks for clarifying Musky but I maintain my optimism that the SP will be well north of $2.20 in 2019 based on all the new products in the ADAPT pipeline HSV2 HPV skin cancer plus the possibilities of additional vacs.
Surely if all these goals are achieved it will have passed $2.20 sometime earlier.
I'm very hopeful !!!
OTR
Reasons to keep holding Admedus shares, page-35
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 73 | $17.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.80 | 9 | 1 |
View Market Depth
| Last trade - 11.19am 22/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable